[go: up one dir, main page]

PE20090801A1 - Derivados de 2,3-benzodiazepina como agentes antipsicoticos - Google Patents

Derivados de 2,3-benzodiazepina como agentes antipsicoticos

Info

Publication number
PE20090801A1
PE20090801A1 PE2008000596A PE2008000596A PE20090801A1 PE 20090801 A1 PE20090801 A1 PE 20090801A1 PE 2008000596 A PE2008000596 A PE 2008000596A PE 2008000596 A PE2008000596 A PE 2008000596A PE 20090801 A1 PE20090801 A1 PE 20090801A1
Authority
PE
Peru
Prior art keywords
benzodiazepine
alkyl
methyl
dimetoxy
dihydro
Prior art date
Application number
PE2008000596A
Other languages
English (en)
Inventor
Emese Csuzdi
Sandor Solyom
Pal Berzsenyi
Ferenc Andrasi
Istvan Sziraki
Katalin Horvath
Zoltan Nagy
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of PE20090801A1 publication Critical patent/PE20090801A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REFERIDA A UN DERIVADO DE 2,3-BENZODIAZEPINA DE FORMULA (I), DONDE R1 ES METILO; R2 ES H; R3 ES -C(=X)-N(R11)(R12), -C(=O)-O-R13, ENTRE OTROS; R11 ES H, ALQUILO C1-C4, FENILO, ENTRE OTROS; R12 ES ALQUILO C1-C4, FENILO, ALCOXI C1-C3, ENTRE OTROS; R13 ES ALQUILO C1-C4 O FENILO; R4, R5, R6, R7 Y R8 SON H, HALOGENO, ALQUILO C1-C3, ENTRE OTROS; R9 Y R10 SON ALCOXI C1-C3. SON COMPUESTOS PREFERIDOS: [R]-1-(4-AMINOFENIL)-7,8-DIMETOXI-4-METIL-3-(1,3-TIAZOL-2-IL)-4,5-DIHIDRO-3H-[2,3]BENZODIAZEPINA, [R]-1-(4-N-ACETIL-AMINOFENIL)-7,8-DIMETOXI-4-METIL-3-(1,3-TIAZOL-2-IL)-4,5-DIHIDRO-3H-[2,3]BENZODIAZEPINA, [R]-1-(4-AMINO-3-METILFENIL)-7,8-DIMETOXI-4-METIL-3-(1,2,4-OXADIAZOL-3-IL)-4,5-DIHIDRO-3H-[2,3]BENZODIAZEPINA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD ANTIPSICOTICA
PE2008000596A 2007-04-02 2008-04-01 Derivados de 2,3-benzodiazepina como agentes antipsicoticos PE20090801A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92153207P 2007-04-02 2007-04-02
US93663107P 2007-06-20 2007-06-20

Publications (1)

Publication Number Publication Date
PE20090801A1 true PE20090801A1 (es) 2009-07-29

Family

ID=39598447

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000596A PE20090801A1 (es) 2007-04-02 2008-04-01 Derivados de 2,3-benzodiazepina como agentes antipsicoticos

Country Status (7)

Country Link
US (1) US20080269202A1 (es)
AR (1) AR065903A1 (es)
CL (1) CL2008000949A1 (es)
IL (1) IL201126A0 (es)
PE (1) PE20090801A1 (es)
TW (1) TW200902024A (es)
WO (1) WO2008124075A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201590356A1 (ru) * 2012-08-16 2015-07-30 Байер Фарма Акциенгезельшафт 2,3-бензодиазепины
MA38346B1 (fr) 2013-02-19 2019-05-31 Bayer Pharma AG 2,3-benzodiazépines bicyclo- et spirocyclosubstituées
CA2915419A1 (en) * 2013-06-17 2014-12-24 Bayer Pharma Aktiengesellschaft Substituted phenyl-2,3-benzodiazepines
WO2015121230A1 (de) * 2014-02-14 2015-08-20 Bayer Pharma Aktiengesellschaft 9-substituierte 2,3-benzodiazepine
CN118161504B (zh) * 2024-05-11 2024-07-19 首都医科大学宣武医院 Ro 5-3335在抗衰老中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
PT771198E (pt) * 1994-08-31 2002-06-28 Lilly Co Eli Derivados de di-hidro-2,3-benzodiazepina
DE19604920A1 (de) * 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
EP1296960A2 (en) * 2000-06-16 2003-04-02 Annovis, Inc. 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors
US6858605B2 (en) * 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives

Also Published As

Publication number Publication date
AR065903A1 (es) 2009-07-08
IL201126A0 (en) 2010-05-17
CL2008000949A1 (es) 2008-10-03
US20080269202A1 (en) 2008-10-30
WO2008124075A1 (en) 2008-10-16
TW200902024A (en) 2009-01-16

Similar Documents

Publication Publication Date Title
PE20140390A1 (es) Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak
PE20110944A1 (es) DERIVADOS DE PIRAZOLO[3,4-d]PIRIMIDINA COMO INHIBIDORES PDE1
PE20090904A1 (es) ARILOXAZOLES SUSTITUIDOS COMO LIGANDOS DE LOS RECEPTORES DE ADENOSINA A1 Y/O A2b
PE20121025A1 (es) Compuestos de benzoxazepina como inhibidores de la p13k
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
HRP20070510T3 (hr) Derivati benzimidazola i njihova upotreba kao antagonista ii receptora
HRP20110498T1 (hr) Azetidini kao inhibitori mek za liječenje proliferativnih bolesti
PE20070181A1 (es) DERIVADOS DE CICLOHEXILAMINISOQUINOLONA COMO INHIBIDORES DE Rho-QUINASA
PE20141557A1 (es) Derivado de pirazoloquinolina
AR067945A1 (es) Pirimidinas biciclicas fusionadas
PE20060842A1 (es) Amino-imidazolonas para la inhibicion de b-secretasa
PE20110995A1 (es) DERIVADOS DE PIRROLO[3,4-e]PIRIMIDINA COMO INHIBIDORES DE PDE1
ECSP067013A (es) 2-quinolil-oxazoles sustituidos útiles como inhibidores de pde4
PE20090801A1 (es) Derivados de 2,3-benzodiazepina como agentes antipsicoticos
PE20060691A1 (es) Serinamidas sustituidas por benzoilo
PE20060285A1 (es) Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
PE20080074A1 (es) Derivados de amida como agentes inhibidores de la quinasa c-fms
PE20020062A1 (es) 5-AMINO-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PIRIMIDINA COMO ANTAGONISTAS RECEPTORES DE ADENOSINA A2a
PE20020592A1 (es) Quinolonas como agentes antimicrobianos
PE20090276A1 (es) Compuestos derivados de imidazoquinolina como moduladores de tlr7
PE20081370A1 (es) Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
TW200744587A (en) Azaindole derivatives exhibiting PGD2 receptor antagonism
TW200734322A (en) Indole derivatives exhibiting PGD2 receptor antagonism
PE20121157A1 (es) Compuestos heterociclicos como inhibidores de proteasas serinas
AR062499A1 (es) Derivados de n-fenil pirazol y piridil pirazoles, composiciones farmaceuticas que los contienen y usos como agentes antiagregantes plaquetarios y antitromboticos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal